BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Mr. Peter Bains as Biocon Group Chief Executive Officer, being a Senior Management Personnel w.e.f. September 18, 2023. Resignation of Mr. Peter Bains as a Non-Executive Independent Director w.e.r. September 18, 2023. BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Mr. Peter Bains as a Non-Executive Independent Director of the Company w.e.f. September 18, 2023. Biocon Biologics integrates Viatris Biosimilars in North America, shares up
Since the acquisition agreement was sealed, Biocon Biologics has implemented an integration plan, overseeing the transition of partners, personnel, systems, and operational processes BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release titled "Biocon Limited announces the acquisition of a manufacturing facility of Eywa Pharma Inc." BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Change in Directorate
The appointment of Mr. Nicholas Robert Haggar as an Additional Director (category: Independent) on the Board of Biocon Limited is effective from September 01, 2023. BIOCON LTD. - 532523 - Intimation Under Regulation 30
Intimation of 1-1 meet with Investor BIOCON LTD. - 532523 - Reporting Of Violations Under SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Reporting of violations by Connected Persons